You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Mallinckrodt
Colorcon
AstraZeneca
Merck

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Litigation Details for Biogen International GMBH v. Stason Pharmaceuticals, Inc. (C.D. Cal. 2017)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Biogen International GMBH v. Stason Pharmaceuticals, Inc. (C.D. Cal. 2017)

Docket   Start Trial Date Filed 2017-06-30
Court District Court, C.D. California Date Terminated 2018-01-11
Cause 15:1126 Patent Infringement Assigned To Cormac J. Carney
Jury Demand Defendant Referred To Jay C. Gandhi
Parties BIOGEN INTERNATIONAL GMBH; BIOGEN MA INC.; SAWAI PHARMACEUTICAL CO., LTD.; STASON PHARMACEUTICALS, INC.
Patents 6,509,376; 7,320,999; 7,619,001; 7,803,840; 8,399,514; 8,759,393
Attorneys Alan Jay Weil; Andrew E Renison; Eric Brin; James B Monroe; Joshua W Sussman; Li Feng; Sanya Sukduang
Firms Finnegan Henderson Farabow Garrett and Dunner; Katten Muchin Rosenman LLP; Kendall Brill & Kelly LLP; Kendall Brill and Kelly LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Biogen International GMBH v. Stason Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Biogen International GMBH v. Stason Pharmaceuticals, Inc. (C.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 2 HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 6,509,376 …Trademarks or ✔ Patents. G ( G the patent action involves…Pharmaceutical Co., Ltd. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT … REPORT ON THE FILING OF AN ACTION Regarding a Patent or a Trademark (Initial Notification) filed by External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
McKinsey
Boehringer Ingelheim
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.